420 related articles for article (PubMed ID: 34200480)
1. VDAC1 Silencing in Cancer Cells Leads to Metabolic Reprogramming That Modulates Tumor Microenvironment.
Zerbib E; Arif T; Shteinfer-Kuzmine A; Chalifa-Caspi V; Shoshan-Barmatz V
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34200480
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial VDAC1 Silencing Leads to Metabolic Rewiring and the Reprogramming of Tumour Cells into Advanced Differentiated States.
Arif T; Paul A; Krelin Y; Shteinfer-Kuzmine A; Shoshan-Barmatz V
Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30544833
[TBL] [Abstract][Full Text] [Related]
3. Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor Hallmarks.
Pandey SK; Machlof-Cohen R; Santhanam M; Shteinfer-Kuzmine A; Shoshan-Barmatz V
Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883451
[TBL] [Abstract][Full Text] [Related]
4. The Mitochondrial Protein VDAC1 at the Crossroads of Cancer Cell Metabolism: The Epigenetic Link.
Amsalem Z; Arif T; Shteinfer-Kuzmine A; Chalifa-Caspi V; Shoshan-Barmatz V
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32331482
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Reprograming Via Silencing of Mitochondrial VDAC1 Expression Encourages Differentiation of Cancer Cells.
Arif T; Amsalem Z; Shoshan-Barmatz V
Mol Ther Nucleic Acids; 2019 Sep; 17():24-37. PubMed ID: 31195298
[TBL] [Abstract][Full Text] [Related]
6. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
[TBL] [Abstract][Full Text] [Related]
7. Silencing the Mitochondrial Gatekeeper VDAC1 as a Potential Treatment for Bladder Cancer.
Alhozeel B; Pandey SK; Shteinfer-Kuzmine A; Santhanam M; Shoshan-Barmatz V
Cells; 2024 Apr; 13(7):. PubMed ID: 38607066
[TBL] [Abstract][Full Text] [Related]
8. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
Arif T; Krelin Y; Shoshan-Barmatz V
Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
[TBL] [Abstract][Full Text] [Related]
9. Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo.
Arif T; Vasilkovsky L; Refaely Y; Konson A; Shoshan-Barmatz V
Mol Ther Nucleic Acids; 2014 Apr; 3(4):e159. PubMed ID: 24781191
[TBL] [Abstract][Full Text] [Related]
10. Knockout of Vdac1 activates hypoxia-inducible factor through reactive oxygen species generation and induces tumor growth by promoting metabolic reprogramming and inflammation.
Brahimi-Horn MC; Giuliano S; Saland E; Lacas-Gervais S; Sheiko T; Pelletier J; Bourget I; Bost F; Féral C; Boulter E; Tauc M; Ivan M; Garmy-Susini B; Popa A; Mari B; Sarry JE; Craigen WJ; Pouysségur J; Mazure NM
Cancer Metab; 2015; 3():8. PubMed ID: 26322231
[TBL] [Abstract][Full Text] [Related]
11. Rewiring of Cancer Cell Metabolism by Mitochondrial VDAC1 Depletion Results in Time-Dependent Tumor Reprogramming: Glioblastoma as a Proof of Concept.
Arif T; Stern O; Pittala S; Chalifa-Caspi V; Shoshan-Barmatz V
Cells; 2019 Oct; 8(11):. PubMed ID: 31661894
[TBL] [Abstract][Full Text] [Related]
12. The Role of Extracellular Vesicles in Metabolic Reprogramming of the Tumor Microenvironment.
Fridman ES; Ginini L; Gil Z
Cells; 2022 Apr; 11(9):. PubMed ID: 35563739
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment signaling and therapeutics in cancer progression.
Goenka A; Khan F; Verma B; Sinha P; Dmello CC; Jogalekar MP; Gangadaran P; Ahn BC
Cancer Commun (Lond); 2023 May; 43(5):525-561. PubMed ID: 37005490
[TBL] [Abstract][Full Text] [Related]
14. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
[TBL] [Abstract][Full Text] [Related]
15. Extracellular matrix (ECM) stiffness and degradation as cancer drivers.
Najafi M; Farhood B; Mortezaee K
J Cell Biochem; 2019 Mar; 120(3):2782-2790. PubMed ID: 30321449
[TBL] [Abstract][Full Text] [Related]
16. ANKRD22, a novel tumor microenvironment-induced mitochondrial protein promotes metabolic reprogramming of colorectal cancer cells.
Pan T; Liu J; Xu S; Yu Q; Wang H; Sun H; Wu J; Zhu Y; Zhou J; Zhu Y
Theranostics; 2020; 10(2):516-536. PubMed ID: 31903135
[No Abstract] [Full Text] [Related]
17. Small extracellular vesicle-mediated metabolic reprogramming: from tumors to pre-metastatic niche formation.
Jiang C; Jiang Z; Sha G; Wang D; Tang D
Cell Commun Signal; 2023 May; 21(1):116. PubMed ID: 37208722
[TBL] [Abstract][Full Text] [Related]
18. VDAC1: from structure to cancer therapy.
Shoshan-Barmatz V; Mizrachi D
Front Oncol; 2012; 2():164. PubMed ID: 23233904
[TBL] [Abstract][Full Text] [Related]
19. Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment.
Tan S; Yang Y; Yang W; Han Y; Huang L; Yang R; Hu Z; Tao Y; Liu L; Li Y; Oyang L; Lin J; Peng Q; Jiang X; Xu X; Xia L; Peng M; Wu N; Tang Y; Cao D; Liao Q; Zhou Y
J Exp Clin Cancer Res; 2023 Mar; 42(1):59. PubMed ID: 36899389
[TBL] [Abstract][Full Text] [Related]
20. Selective induction of cancer cell death by VDAC1-based peptides and their potential use in cancer therapy.
Shteinfer-Kuzmine A; Amsalem Z; Arif T; Zooravlov A; Shoshan-Barmatz V
Mol Oncol; 2018 Jun; 12(7):1077-1103. PubMed ID: 29698587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
